Back to search
FDAFDA · Food and drugs·Recall number D-0345-2018

Limbrel (flavocoxid 500 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ 85253; Manufactured by: Cornerstone Research and Development, Ogden, UT 84404, NDC 68040-602-16.

Published February 21, 2018 · Recall initiated: January 26, 2018

Summary

FDA records drug Class I recall D-0345-2018, published February 21, 2018 and initiated January 26, 2018. Recalling firm: Primus Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 135,277 bottles; Lot: All lots within expiry. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Primus Pharmaceuticals, Inc.
Distributor
Nationwide in the USA.
Lot
All lots within expiry.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Limbrel (flavocoxid 500 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ 85253; Manufactured by: Cornerstone Research and Development, Ogden, UT 84404, NDC 68040-602-16. recalled?

Yes. FDA published recall D-0345-2018 on February 21, 2018. Reported hazard: Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release